Search alternatives:
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
significant factors » significant predictors (Expand Search)
factors decrease » factors increases (Expand Search)
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
significant factors » significant predictors (Expand Search)
factors decrease » factors increases (Expand Search)
-
1501
-
1502
-
1503
-
1504
-
1505
-
1506
-
1507
Recruitment flow diagram of the current study.
Published 2025“…Phase 1 EQ-VAS decreases were associated with female sex, lower somatic symptom, fewer comorbidities, lack of expectation for a fast recovery, higher ISS, higher injury pain, neck, spine/back or lower extremity injuries. …”
-
1508
DataSheet1_Significant nocturnal wakefulness after sleep onset in metabolic dysfunction–associated steatotic liver disease.PDF
Published 2024“…HC 45.4 min vs. 21.3 min, p = 0.0004), and decreased sleep efficiency (MASLD vs. HC 86.5% vs. 92.8%, p = 0.0008) compared with HC despite comparable sleep duration. …”
-
1509
DataSheet3_Significant nocturnal wakefulness after sleep onset in metabolic dysfunction–associated steatotic liver disease.PDF
Published 2024“…HC 45.4 min vs. 21.3 min, p = 0.0004), and decreased sleep efficiency (MASLD vs. HC 86.5% vs. 92.8%, p = 0.0008) compared with HC despite comparable sleep duration. …”
-
1510
DataSheet2_Significant nocturnal wakefulness after sleep onset in metabolic dysfunction–associated steatotic liver disease.PDF
Published 2024“…HC 45.4 min vs. 21.3 min, p = 0.0004), and decreased sleep efficiency (MASLD vs. HC 86.5% vs. 92.8%, p = 0.0008) compared with HC despite comparable sleep duration. …”
-
1511
DataSheet4_Significant nocturnal wakefulness after sleep onset in metabolic dysfunction–associated steatotic liver disease.PDF
Published 2024“…HC 45.4 min vs. 21.3 min, p = 0.0004), and decreased sleep efficiency (MASLD vs. HC 86.5% vs. 92.8%, p = 0.0008) compared with HC despite comparable sleep duration. …”
-
1512
-
1513
-
1514
-
1515
-
1516
-
1517
-
1518
Determination of SCFA content in fecal stool and intestinal metabolites of rats in each group.
Published 2025Subjects: -
1519
-
1520